PubMed HealthSearch

Biomedical subjects

R Irby

Publications and source records attributed to R Irby.

15 recordsLinked to original sources

Enzymatic preparation of [2,4,5,6,8-14C, 5'-3H]guanosine for use in biosynthetic studies of pterinoid and flavin compounds.

To aid in investigations on the biosynthesis of pterinoid compounds, a procedure was developed for the preparation of double-labeled guanosine with 3H in the ribose moiety and 14C in the guanine ring. Ribose, as ribose-1-phosphate, was removed from [2,8,5'-3H]adenosine in a reaction using purine nucleoside phosphorylase and was coupled to unlabeled guanine using the same enzyme. The procedure was accomplished in one tube with no purification of intermediates necessary. The final product, [5'-3H]guanosine, was purified by affinity chromatography using a boronate column. The overall yield of labeled guanosine is about 91%. HPLC analysis indicates the radiochemical purity at 98%. The purity of the guanosine makes it suitable for in vivo studies of flavins, pterins, and other guanosine-derived compounds. A doubly labeled preparation was achieved by the addition of [5'-3H]guanosine to 14C-labeled guanosine in which only the guanine ring is labeled. The latter was formed in a manner similar to the one above. In this case, the labeled ribose moiety was enzymatically removed from [U-14C]guanosine and replaced with unlabeled ribose.

Carbon Radioisotopes

Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.

Weekly treatment with low-dose oral methotrexate (MTX) was compared with daily auranofin (AUR) treatment in a 36-week double-blind, randomized, multicenter study of 281 patients with active, adult-onset rheumatoid arthritis. Both treatment groups showed significant improvement by the usual measures of clinical efficacy. The response with MTX occurred earlier and was consistently greater than that with AUR. An intent-to-treat analysis showed significantly greater improvement (P less than 0.01) with MTX for painful and swollen joint counts and physician and patient global assessments of disease activity. Adverse reactions were reported more frequently in the AUR group, and more AUR-treated patients were withdrawn from the study because of toxicity. MTX was thus more effective and better tolerated than AUR in this study.

Administration, Oral

Articular complications of homotransplantation and chronic renal hemodialysis.

Renal homotransplantaion and chronic hemodialysis are accepted methods of treating end-stage kidney disease. However, these procedures are fraught with complications involving bones, joints, and soft tissues. Transplantation and immunosuppressive therapy problems include "connective tissue-like" reactions, infections in joints and avascular necrosis of bone. Long term hemodialysis may accentuate secondary hyperparathyroidism, renal osteodystrophy, and metastatic calcification, which can be minimized by phosphorous control or calcium loading in the dialysate. In the presence of osteomalacia, vitamin D may be helpful and parathyroidectomy is indicated if autonomy is present. In one patient undergoing long term hemodialysis, a chalky material was aspirated from the olecranon bursa. Two inorganic solid phases were identified as being present - a major phase, octacalcium phosphate (ocp) and a minor phase, calcite (CaCO3). Because of its elusive properties, the role of OCP in biological systems is poorly known and can easily escape detection. Methods of identification of OCP and its potential role in crystal deposition syndromes are discussed.

Bone Diseases